Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Coronavirus restrictions, SAP slump hit European stocks

Published 10/26/2020, 04:20 AM
Updated 10/26/2020, 05:50 AM
© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt

By Sruthi Shankar

(Reuters) - European stocks fell on Monday as Italy and Spain imposed fresh restrictions to control a resurgence in coronavirus cases, while shares in German heavyweight SAP slumped after it cut its 2020 outlook.

The pan-European STOXX 600 index (STOXX) declined 0.5% and the euro zone blue-chip index (STOXX50E) tumbled 1.4%, with risk appetite globally sapped by worries over slow progress on a new U.S. stimulus bill and looming presidential election.

The German DAX (GDAXI) dropped 2.0% after software company SAP (DE:SAPG) abandoned medium-term profitability targets and cautioned that its business would take longer than expected to recover from the pandemic hit.

Shares of Europe's most valuable tech firm tumbled 18%, set for their worst decline in 24 years, with the wider tech index (SX8P) down 5.2%.

SAP's earnings came as a blip in the third-quarter earnings season, which has been largely better than feared.

Meanwhile, Italy has ordered bars and restaurants to close by 6 p.m. and to shut public gyms, cinemas, while Spanish Prime Minister Pedro Sanchez announced a new state of emergency as many Southern European countries reported their highest number of COVID-19 cases in a single day.

Europe on Saturday became the second region after Latin America to surpass 250,000 deaths, according to a Reuters tally.

Nick Nelson, head of European equity strategy at UBS, said the Swiss bank's target for STOXX 600 into the year-end is 340 points, about 5% below the current level, in part due to the impact of the latest round of restrictions.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Not a large move, but we see some modest downside into year-end partly because of the mobility restrictions and a slowdown in the macro momentum with PMIs falling below 50," he said.

Surveys of euro zone purchasing managers last week showed economic activity slipped back into decline in October, heightening expectations for a double-dip recession as a second wave of virus sweeps across the continent.

Milan's blue-chip index (FTMIB) fell 0.9%, even as ratings agency Standard and Poor's (NYSE:SPY) upgraded Italy's sovereign outlook to stable from negative.

Oil majors Total (PA:TOTF) and Royal Dutch Shell (L:RDSa) fell over 1% as crude prices slumped almost 3% on worries surging COVID-19 cases in the United States and Europe would hurt demand. [O/R]

London's FTSE 100 (FTSE) was flat as banks found support after a media report that UK regulators are considering plans to allow banks to start paying dividends again next year. (L)

Healthcare stocks (SXDP) also remained supportive, with AstraZeneca (L:AZN) gaining 1.1% after it resumed the U.S. trial of its experimental COVID-19 vaccine.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.